URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sandra McDonald

Concepts (176)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Biological Specimen Banks
2
2011
6
1.610
Why?
Carcinoma, Non-Small-Cell Lung
5
1993
66
0.860
Why?
Genomics
1
2012
43
0.800
Why?
Individualized Medicine
1
2011
5
0.780
Why?
Lung Neoplasms
7
1987
422
0.680
Why?
Lung
6
1989
1132
0.480
Why?
Head and Neck Neoplasms
4
1987
78
0.450
Why?
Interferon-beta
2
1993
60
0.420
Why?
Radiotherapy
2
1988
179
0.260
Why?
Radiotherapy Dosage
5
1987
185
0.240
Why?
Amifostine
1
1994
25
0.230
Why?
Radiation Injuries
2
1988
123
0.230
Why?
Salivary Glands
1
1994
62
0.230
Why?
Humans
19
1987
35000
0.220
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
22
0.220
Why?
Genetic Research
1
2012
1
0.210
Why?
Pulmonary Fibrosis
2
1989
130
0.210
Why?
Aromatase
1
2012
4
0.210
Why?
Aromatase Inhibitors
1
2012
4
0.210
Why?
Alleles
1
2013
200
0.210
Why?
Ethics Committees, Research
1
2012
17
0.200
Why?
Genome, Human
1
2012
32
0.200
Why?
Information Dissemination
1
2012
24
0.200
Why?
RNA Splicing
1
2013
142
0.190
Why?
Informed Consent
1
2011
77
0.190
Why?
Quality Assurance, Health Care
1
2012
114
0.190
Why?
Pneumonia
2
1989
188
0.180
Why?
Physician's Role
1
2011
119
0.180
Why?
Carcinoma, Squamous Cell
2
1987
230
0.180
Why?
Drug Resistance, Neoplasm
1
2010
54
0.170
Why?
Insulin-Like Growth Factor I
1
2010
98
0.170
Why?
Laryngeal Neoplasms
1
1989
18
0.170
Why?
Neoplasms, Multiple Primary
1
1989
39
0.170
Why?
Cisplatin
2
1987
93
0.160
Why?
Smoking
1
2012
387
0.160
Why?
Neoplasm Metastasis
1
1987
219
0.140
Why?
Combined Modality Therapy
3
1987
459
0.140
Why?
Antibodies, Monoclonal
1
2010
725
0.130
Why?
Breast Neoplasms
1
2012
660
0.130
Why?
Radiation Pneumonitis
2
1995
37
0.120
Why?
Cystadenocarcinoma, Serous
1
2004
6
0.120
Why?
Cystadenocarcinoma, Papillary
1
2004
10
0.120
Why?
Adenocarcinoma, Clear Cell
1
2004
10
0.120
Why?
Dose-Response Relationship, Radiation
3
1989
205
0.120
Why?
Endometrial Neoplasms
1
2004
36
0.120
Why?
Brachytherapy
1
2004
108
0.110
Why?
Prognosis
4
1987
1030
0.110
Why?
Female
12
1987
19061
0.110
Why?
Exons
2
2012
165
0.100
Why?
Radiation Tolerance
2
1989
78
0.100
Why?
Survival Rate
2
1993
584
0.090
Why?
Neoplasms
1
1987
701
0.090
Why?
Recombinant Proteins
2
1993
706
0.090
Why?
Pilot Projects
2
1987
426
0.090
Why?
Male
8
1988
18870
0.080
Why?
Pulmonary Surfactants
2
1989
244
0.080
Why?
Middle Aged
6
1987
9461
0.080
Why?
Aged, 80 and over
3
1989
2423
0.070
Why?
Aged
5
1989
6986
0.070
Why?
Feasibility Studies
2
1992
189
0.070
Why?
Retrospective Studies
4
1994
2167
0.070
Why?
Radiation Dosage
2
1993
115
0.070
Why?
Antineoplastic Agents
2
2010
598
0.060
Why?
Adult
5
1987
10906
0.060
Why?
Respiratory Function Tests
1
1995
121
0.060
Why?
Fatigue
1
1996
122
0.060
Why?
Clinical Protocols
1
1995
102
0.060
Why?
Time Factors
2
1987
3047
0.060
Why?
Sodium Pertechnetate Tc 99m
1
1994
9
0.060
Why?
Secretory Rate
1
1994
40
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1989
297
0.060
Why?
Radiation Protection
1
1994
22
0.060
Why?
DNA, Neoplasm
1
1994
127
0.060
Why?
Parotid Gland
1
1994
74
0.060
Why?
Follow-Up Studies
2
1987
1757
0.060
Why?
Antigens, Neoplasm
1
1994
105
0.050
Why?
Procollagen
1
1993
9
0.050
Why?
Cesium Radioisotopes
1
1993
27
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2013
22
0.050
Why?
INDEL Mutation
1
2012
1
0.050
Why?
Radiation-Protective Agents
1
1993
38
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2012
6
0.050
Why?
Radiation-Sensitizing Agents
1
1993
72
0.050
Why?
Exome
1
2012
2
0.050
Why?
Genome-Wide Association Study
1
2012
22
0.050
Why?
MAP Kinase Kinase Kinase 1
1
2012
5
0.050
Why?
Mice
3
1993
5900
0.050
Why?
Animals
5
1989
15647
0.050
Why?
Mice, Inbred Strains
1
1993
238
0.050
Why?
MAP Kinase Kinase 4
1
2012
23
0.050
Why?
Molecular Targeted Therapy
1
2012
20
0.050
Why?
Nitriles
1
2012
39
0.050
Why?
Respiration
1
1993
176
0.050
Why?
Androstadienes
1
2012
33
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
409
0.050
Why?
Microcomputers
1
1992
11
0.050
Why?
Evaluation Studies as Topic
2
1987
240
0.050
Why?
Radiotherapy, Computer-Assisted
1
1992
14
0.050
Why?
Chromosome Aberrations
1
2012
114
0.050
Why?
Phospholipids
1
1993
178
0.050
Why?
Triazoles
1
2012
40
0.050
Why?
Cytokines
1
1995
555
0.050
Why?
Genetic Variation
1
2012
148
0.050
Why?
DNA Primers
1
2013
401
0.050
Why?
Point Mutation
1
2012
169
0.050
Why?
Medical Oncology
1
1992
40
0.050
Why?
Severity of Illness Index
1
1995
878
0.050
Why?
Receptors, Estrogen
1
2012
180
0.050
Why?
Sensitivity and Specificity
1
1994
866
0.050
Why?
Clinical Trials as Topic
1
1994
664
0.050
Why?
DNA Repair
1
2012
168
0.050
Why?
Clinical Trials, Phase II as Topic
1
2010
13
0.050
Why?
NIH 3T3 Cells
1
2010
25
0.050
Why?
Tissue Array Analysis
1
2010
35
0.040
Why?
Molecular Diagnostic Techniques
1
2010
10
0.040
Why?
Nuclear Proteins
1
1994
333
0.040
Why?
Immunoglobulins, Intravenous
1
2010
38
0.040
Why?
Gene Expression Profiling
1
2012
296
0.040
Why?
Hormone Antagonists
1
2010
44
0.040
Why?
Pulmonary Surfactant-Associated Proteins
1
1989
26
0.040
Why?
Apoproteins
1
1989
25
0.040
Why?
Radiation Injuries, Experimental
1
1989
82
0.040
Why?
Treatment Outcome
2
1996
2487
0.040
Why?
Base Sequence
1
2013
1681
0.040
Why?
Liver
1
2013
870
0.040
Why?
Whole-Body Irradiation
1
1989
78
0.040
Why?
Radioisotope Teletherapy
1
1987
3
0.040
Why?
Cobalt Radioisotopes
1
1987
16
0.040
Why?
Internship and Residency
1
1992
323
0.040
Why?
Colorectal Neoplasms
1
1989
138
0.040
Why?
Thoracic Neoplasms
1
1987
17
0.040
Why?
Infusions, Intravenous
1
1987
139
0.040
Why?
Lymphatic Metastasis
1
1987
137
0.040
Why?
Mutation
1
2012
1183
0.030
Why?
Palliative Care
1
1987
151
0.030
Why?
Brain Neoplasms
1
1988
254
0.030
Why?
Iridium Radioisotopes
1
2004
13
0.030
Why?
Radiopharmaceuticals
1
2004
48
0.030
Why?
Tomography, X-Ray Computed
1
1988
729
0.030
Why?
Disease-Free Survival
1
2004
191
0.030
Why?
Prostatic Neoplasms
1
1989
548
0.030
Why?
Neoplasm Staging
1
2004
326
0.030
Why?
Magnetic Resonance Imaging
1
1988
928
0.030
Why?
United States
1
1989
2511
0.020
Why?
Brain
1
1988
1161
0.020
Why?
Adolescent
1
1987
4513
0.020
Why?
Etoposide
1
1996
73
0.020
Why?
Chemotherapy, Adjuvant
1
1996
85
0.020
Why?
Antineoplastic Agents, Phytogenic
1
1996
38
0.020
Why?
Radiotherapy, Adjuvant
1
1996
72
0.020
Why?
Treatment Failure
1
1996
125
0.020
Why?
Administration, Oral
1
1996
302
0.020
Why?
Drug Administration Schedule
1
1996
362
0.020
Why?
Platelet-Derived Growth Factor
1
1995
105
0.020
Why?
Ploidies
1
1994
18
0.010
Why?
Autoantigens
1
1994
35
0.010
Why?
Interleukin-1
1
1995
204
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1994
48
0.010
Why?
Fibronectins
1
1995
144
0.010
Why?
Collagen
1
1995
270
0.010
Why?
Survival Analysis
1
1996
575
0.010
Why?
Fluorescent Antibody Technique
1
1994
287
0.010
Why?
Disease Progression
1
1996
496
0.010
Why?
Biopsy
1
1994
359
0.010
Why?
Transforming Growth Factor beta
1
1995
362
0.010
Why?
Predictive Value of Tests
1
1994
579
0.010
Why?
Computer Graphics
1
1992
17
0.010
Why?
Computer-Assisted Instruction
1
1992
20
0.010
Why?
Analysis of Variance
1
1994
705
0.010
Why?
Flow Cytometry
1
1994
597
0.010
Why?
Depression
1
1996
419
0.010
Why?
Mice, Inbred C57BL
1
1995
1613
0.010
Why?
Astrocytoma
1
1988
26
0.010
Why?
Glioblastoma
1
1988
55
0.010
Why?
Rabbits
1
1989
686
0.010
Why?
Biological Markers
1
1989
532
0.010
Why?

Visualizations


McDonald's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department